{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:13:15Z","timestamp":1790115195493,"version":"4.0.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,1,30]],"date-time":"2008-01-30T00:00:00Z","timestamp":1201651200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2008,1,30]],"date-time":"2008-01-30T00:00:00Z","timestamp":1201651200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Resistin is a cystein-rich secretory adipokine. It is proposed to have proinflammatory properties in humans. The aim of this study was to determine associations between serum levels of resistin and markers of inflammation and bone mineral density (BMD) in female patients with systemic lupus erythematosus (SLE).<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>One hundred sixty-three female patients with SLE (20 to 82 years old) were examined in a cross-sectional study. Venous blood samples were analyzed for resistin, erythrocyte sedimentation rate (ESR), C-reactive protein, creatinine, fasting lipids, complements, tumor necrosis factor-alpha, interleukin (IL)-1\u03b2, IL-6, sIL-6R (soluble IL-6 receptor), ICTP (C-terminal telopeptide of type I collagen), and PINP (N-terminal propeptide of type I procollagen). Simple and multiple regression analyses as well as logistic regression analyses were performed. Resistin in serum was compared with 42 healthy female controls with respect to age.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>Serum resistin levels in controls were similar to those of patients with SLE. Markers of inflammation and current dose of glucocorticosteroids correlated positively to resistin in serum. Markers of renal function, number of prevalent vertebral fractures, and BMD were also significantly associated with resistin. In a multiple regression model, ESR, creatinine, C3, current glucocorticosteroid dose, high-density lipoprotein, and BMD radius remained significantly associated with resistin. In logistic regression analyses with resistin as the independent variable, a significant association was found with ESR (normal or elevated) but not with S-creatinine or <jats:italic>z<\/jats:italic> score for hip and radius total.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusion<\/jats:title>\n                        <jats:p>Although resistin measurements did not differ between patients and controls, resistin was clearly associated with general inflammation, renal disease, treatment with glucocorticosteroids, and bone loss. We hypothesize that resistin has proinflammatory and disease-promoting properties in SLE. Further studies are needed to elucidate the mechanism behind these associations.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/ar2366","type":"journal-article","created":{"date-parts":[[2008,1,30]],"date-time":"2008-01-30T19:14:31Z","timestamp":1201720471000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Role of resistin as a marker of inflammation in systemic lupus erythematosus"],"prefix":"10.1186","volume":"10","author":[{"given":"Katarina","family":"Almehed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena Forsblad","family":"d'Elia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bokarewa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Carlsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,1,30]]},"reference":[{"key":"2216_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/35053000","volume":"409","author":"CM Steppan","year":"2001","unstructured":"Steppan CM, Bailey ST, Bhat S, Brown EJ, Banerjee RR, Wright CM, Patel HR, Ahima RS, Lazar MA: The hormone resistin links obesity to diabetes. Nature. 2001, 409: 307-312. 10.1038\/35053000.","journal-title":"Nature"},{"key":"2216_CR2","doi-asserted-by":"publisher","first-page":"11252","DOI":"10.1074\/jbc.C100028200","volume":"276","author":"KH Kim","year":"2001","unstructured":"Kim KH, Lee K, Moon YS, Sul HS: A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J Biol Chem. 2001, 276: 11252-11256. 10.1074\/jbc.C100028200.","journal-title":"J Biol Chem"},{"key":"2216_CR3","doi-asserted-by":"publisher","first-page":"4046","DOI":"10.1093\/emboj\/19.15.4046","volume":"19","author":"IN Holcomb","year":"2000","unstructured":"Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, Nelson C, Lowman HB, Wright BD, Skelton NJ, Frantz GD, Tumas DB, Peale FV, Shelton DL, H\u00e9bert CC: FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J. 2000, 19: 4046-4055. 10.1093\/emboj\/19.15.4046.","journal-title":"EMBO J"},{"key":"2216_CR4","first-page":"698","volume":"24","author":"K Migita","year":"2006","unstructured":"Migita K, Maeda Y, Miyashita T, Kimura H, Nakamura M, Ishibashi H, Eguchi K: The serum levels ofresistin in rheumatoid arthritis patients. Clin Exp Rheumatol. 2006, 24: 698-701.","journal-title":"Clin Exp Rheumatol"},{"key":"2216_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/01.MIB.0000200345.38837.46","volume":"12","author":"K Karmiris","year":"2006","unstructured":"Karmiris K, Koutroubakis IE, Xidakis C, Polychronaki M, Voudouri T, Kouroumalis EA: Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis. 2006, 12: 100-105. 10.1097\/01.MIB.0000200345.38837.46.","journal-title":"Inflamm Bowel Dis"},{"key":"2216_CR6","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/01.mol.0000217899.59820.9a","volume":"17","author":"PG McTernan","year":"2006","unstructured":"McTernan PG, Kusminski CM, Kumar S: Resistin. Curr Opin Lipidol. 2006, 17: 170-175. 10.1097\/01.mol.0000217899.59820.9a.","journal-title":"Curr Opin Lipidol"},{"key":"2216_CR7","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1016\/j.transproceed.2006.10.140","volume":"38","author":"J Malyszko","year":"2006","unstructured":"Malyszko J, Malyszko JS, Pawlak K, Mysliwiec M: Resistin, a new adipokine, is related to inflammation and renal function in kidney allograft recipients. Transplant Proc. 2006, 38: 3434-3436. 10.1016\/j.transproceed.2006.10.140.","journal-title":"Transplant Proc"},{"key":"2216_CR8","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.metabol.2006.08.008","volume":"55","author":"H Hui-Bing","year":"2006","unstructured":"Hui-Bing H, Migita K, Miyashita T, Maeda Y, Nakamura M, Yatsuhashi H, Ishibashi H, Eguchi K, Kimura H: Relationship between serum resistin concentrations and inflammatory markers in patients with type 2 diabetes mellitus. Metabolism. 2006, 55: 1670-1673. 10.1016\/j.metabol.2006.08.008.","journal-title":"Metabolism"},{"key":"2216_CR9","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S0006-291X(02)02841-3","volume":"300","author":"L Patel","year":"2003","unstructured":"Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, Macphee CH, Smith SA: Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun. 2003, 300: 472-476. 10.1016\/S0006-291X(02)02841-3.","journal-title":"Biochem Biophys Res Commun"},{"key":"2216_CR10","doi-asserted-by":"publisher","first-page":"e31","DOI":"10.1371\/journal.pone.0000031","volume":"1","author":"I Nagaev","year":"2006","unstructured":"Nagaev I, Bokarewa M, Tarkowski A, Smith U: Human resistin is a systemic immune-derived proinflammatory cytokine targeting both leukocytes and adipocytes. PLoS ONE. 2006, 1: e31-10.1371\/journal.pone.0000031.","journal-title":"PLoS ONE"},{"key":"2216_CR11","doi-asserted-by":"publisher","first-page":"5789","DOI":"10.4049\/jimmunol.174.9.5789","volume":"174","author":"M Bokarewa","year":"2005","unstructured":"Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A: Resistin, an adipokine with potent proinflammatory properties. J Immunol. 2005, 174: 5789-5795.","journal-title":"J Immunol"},{"key":"2216_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cyto.2007.02.003","volume":"37","author":"S Yaturu","year":"2007","unstructured":"Yaturu S, Reddy RD, Rains J, Jain SK: Plasma and urine levels of resistin and adiponectin in chronic kidney disease. Cytokine. 2007, 37: 1-5. 10.1016\/j.cyto.2007.02.003.","journal-title":"Cytokine"},{"key":"2216_CR13","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1002\/jcb.20915","volume":"99","author":"L Thommesen","year":"2006","unstructured":"Thommesen L, Stunes AK, Monjo M, Gr\u00f8svik K, Tamburstuen MV, Kj\u00f8bli E, Lyngstadaas SP, Reseland JE, Syversen U: Expression and regulation of resistin in osteoblasts and osteoclasts indicate a role in bone metabolism. J Cell Biochem. 2006, 99: 824-834. 10.1002\/jcb.20915.","journal-title":"J Cell Biochem"},{"key":"2216_CR14","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1093\/rheumatology\/kem105","volume":"46","author":"K Almehed","year":"2007","unstructured":"Almehed K, Forsblad d'Elia H, Kvist G, Ohlsson C, Carlsten H: Prevalence and risk factors of osteoporosis in female SLE patients-extended report. Rheumatology (Oxford). 2007, 46: 1185-1190. 10.1093\/rheumatology\/kem105.","journal-title":"Rheumatology (Oxford)"},{"key":"2216_CR15","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.1780251101","volume":"25","author":"EM Tan","year":"1982","unstructured":"Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982, 25: 1271-1277. 10.1002\/art.1780251101.","journal-title":"Arthritis Rheum"},{"key":"2216_CR16","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/art.1780350606","volume":"35","author":"C Bombardier","year":"1992","unstructured":"Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH: Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992, 35: 630-640. 10.1002\/art.1780350606.","journal-title":"Arthritis Rheum"},{"key":"2216_CR17","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/art.1780400506","volume":"40","author":"DD Gladman","year":"1997","unstructured":"Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C, Hanly JG, Isenberg DA, Kalunian K, Nived O, Petri M, Sanchez-Guerrero J, Snaith M, Sturfelt G: The reliability of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum. 1997, 40: 809-813. 10.1002\/art.1780400506.","journal-title":"Arthritis Rheum"},{"key":"2216_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron. 1976, 16: 31-41.","journal-title":"Nephron"},{"key":"2216_CR19","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","volume":"8","author":"HK Genant","year":"1993","unstructured":"Genant HK, Wu CY, van Kuijk C, Nevitt MC: Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993, 8: 1137-1148.","journal-title":"J Bone Miner Res"},{"key":"2216_CR20","doi-asserted-by":"publisher","first-page":"894","DOI":"10.2337\/diacare.25.5.894","volume":"25","author":"AI Adler","year":"2002","unstructured":"Adler AI, Stevens RJ, Neil A, Stratton IM, Boulton AJ, Holman RR: UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care. 2002, 25: 894-899. 10.2337\/diacare.25.5.894.","journal-title":"Diabetes Care"},{"key":"2216_CR21","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1136\/ard.2006.054734","volume":"66","author":"L Senolt","year":"2007","unstructured":"Senolt L, Housa D, Vernerov\u00e1 Z, Jir\u00e1sek T, Svobodov\u00e1 R, Veigl D, Anderlov\u00e1 K, M\u00fcller-Ladner U, Pavelka K, Haluz\u00edk M: Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis. 2007, 66: 458-463. 10.1136\/ard.2006.054734.","journal-title":"Ann Rheum Dis"},{"key":"2216_CR22","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1530\/eje.1.02311","volume":"156","author":"I Pantsulaia","year":"2007","unstructured":"Pantsulaia I, Livshits G, Trofimov S, Kobyliansky E: Genetic and environmental determinants of circulating resistin level in a community-based sample. Eur J Endocrinol. 2007, 156: 129-135. 10.1530\/eje.1.02311.","journal-title":"Eur J Endocrinol"},{"key":"2216_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0014-5793(01)02968-4","volume":"507","author":"F Haugen","year":"2001","unstructured":"Haugen F, Jorgensen A, Drevon CA, Trayhurn P: Inhibition by insulin of resistin gene expression in 3T3-L1 adipocytes. FEBS Lett. 2001, 507: 105-108. 10.1016\/S0014-5793(01)02968-4.","journal-title":"FEBS Lett"},{"key":"2216_CR24","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.2337\/dc06-1936","volume":"30","author":"H Osawa","year":"2007","unstructured":"Osawa H, Tabara Y, Kawamoto R, Ohashi J, Ochi M, Onuma H, Nishida W, Yamada K, Nakura J, Kohara K, Miki T, Makino H: Plasma resistin, associated with single nucleotide polymorphism -420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population. Diabetes Care. 2007, 30: 1501-1506. 10.2337\/dc06-1936.","journal-title":"Diabetes Care"},{"key":"2216_CR25","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1530\/eje.1.02338","volume":"156","author":"GD Norata","year":"2007","unstructured":"Norata GD, Ongari M, Garlaschelli K, Raselli S, Grigore L, Catapano AL: Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur J Endocrinol. 2007, 156: 279-284. 10.1530\/eje.1.02338.","journal-title":"Eur J Endocrinol"},{"key":"2216_CR26","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1002\/art.11264","volume":"48","author":"E Svenungsson","year":"2003","unstructured":"Svenungsson E, Gunnarsson I, Fei GZ, Lundberg IE, Klareskog L, Frostegard J: Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha\/tumor necrosis factor receptor system in systemic lupus erythematosus. Arthritis Rheum. 2003, 48: 2533-2540. 10.1002\/art.11264.","journal-title":"Arthritis Rheum"},{"key":"2216_CR27","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1177\/096120339700600610","volume":"6","author":"EF Borba","year":"1997","unstructured":"Borba EF, Bonfa E: Dyslipoproteinemias in systemic lupus erythematosus: influence of disease, activity, and anticardiolipin antibodies. Lupus. 1997, 6: 533-539. 10.1177\/096120339700600610.","journal-title":"Lupus"},{"key":"2216_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00296-006-0195-3","volume":"27","author":"S Kashef","year":"2007","unstructured":"Kashef S, Ghaedian MM, Rajaee A, Ghaderi A: Dyslipoproteinemia during the active course of systemic lupus erythematosus in association with anti-double-stranded DNA (anti-dsDNA) antibodies. Rheumatol Int. 2007, 27: 235-241. 10.1007\/s00296-006-0195-3.","journal-title":"Rheumatol Int"},{"key":"2216_CR29","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/0002-9343(87)90762-5","volume":"83","author":"WH Ettinger","year":"1987","unstructured":"Ettinger WH, Goldberg AP, Applebaum-Bowden D, Hazzard WR: Dyslipoproteinemia in systemic lupus erythematosus. Effect of corticosteroids. Am J Med. 1987, 83: 503-508. 10.1016\/0002-9343(87)90762-5.","journal-title":"Am J Med"},{"key":"2216_CR30","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1194\/jlr.R300019-JLR200","volume":"45","author":"W Khovidhunkit","year":"2004","unstructured":"Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C: Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res. 2004, 45: 1169-1196. 10.1194\/jlr.R300019-JLR200.","journal-title":"J Lipid Res"},{"key":"2216_CR31","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jaut.2007.02.004","volume":"28","author":"BH Hahn","year":"2007","unstructured":"Hahn BH, Grossman J, Chen W, McMahon M: The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: Roles of inflammation and dyslipidemia. J Autoimmun. 2007, 28: 69-75. 10.1016\/j.jaut.2007.02.004.","journal-title":"J Autoimmun"},{"key":"2216_CR32","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.cca.2006.07.026","volume":"376","author":"L Risch","year":"2007","unstructured":"Risch L, Saely C, Hoefle G, Rein P, Langer P, Gouya G, Marte T, Aczel S, Drexel H: Relationship between glomerular filtration rate and the adipokines adiponectin, resistin and leptin in coronary patients with predominantly normal or mildly impaired renal function. Clin Chim Acta. 2007, 376: 108-113. 10.1016\/j.cca.2006.07.026.","journal-title":"Clin Chim Acta"},{"key":"2216_CR33","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1093\/ndt\/gfi084","volume":"21","author":"KD Nusken","year":"2006","unstructured":"Nusken KD, Kratzsch J, Wienholz V, Stohr W, Rascher W, Dotsch J: Circulating resistin concentrations in children depend on renal function. Nephrol Dial Transplant. 2006, 21: 107-112. 10.1093\/ndt\/gfi084.","journal-title":"Nephrol Dial Transplant"},{"key":"2216_CR34","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.bbrc.2003.07.003","volume":"309","author":"S Kaser","year":"2003","unstructured":"Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR: Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun. 2003, 309: 286-290. 10.1016\/j.bbrc.2003.07.003.","journal-title":"Biochem Biophys Res Commun"},{"key":"2216_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1111\/j.1365-2265.2005.02312.x","volume":"63","author":"KW Oh","year":"2005","unstructured":"Oh KW, Lee WY, Rhee EJ, Baek KH, Yoon KH, Kang MI, Yun EJ, Park CY, Ihm SH, Choi MG, Yoo HJ, Park SW: The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin Endocrinol (Oxf). 2005, 63: 131-138. 10.1111\/j.1365-2265.2005.02312.x.","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar2366.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/ar2366\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/ar2366.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:29:19Z","timestamp":1728383359000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/ar2366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,30]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2008,2]]}},"alternative-id":["2216"],"URL":"https:\/\/doi.org\/10.1186\/ar2366","relation":{},"ISSN":["1478-6354"],"issn-type":[{"value":"1478-6354","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,30]]},"assertion":[{"value":"26 September 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2008","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2008","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R15"}}